A Metabolomics Approach to Increasing Chinese Hamster Ovary (CHO) Cell Productivity. 2021

Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
Bristol Myers Squibb, Biologics Development, Devens, MA 01434, USA.

Much progress has been made in improving the viable cell density of bioreactor cultures in monoclonal antibody production from Chinese hamster ovary (CHO) cells; however, specific productivity (qP) has not been increased to the same degree. In this work, we analyzed a library of 24 antibody-expressing CHO cell clones to identify metabolites that positively associate with qP and could be used for clone selection or medium supplementation. An initial library of 12 clones, each producing one of two antibodies, was analyzed using untargeted LC-MS experiments. Metabolic model-based annotation followed by correlation analysis detected 73 metabolites that significantly correlated with growth, qP, or both. Of these, metabolites in the alanine, aspartate, and glutamate metabolism pathway, and the TCA cycle showed the strongest association with qP. To evaluate whether these metabolites could be used as indicators to identify clones with potential for high productivity, we performed targeted LC-MS experiments on a second library of 12 clones expressing a third antibody. These experiments found that aspartate and cystine were positively correlated with qP, confirming the results from untargeted analysis. To investigate whether qP correlated metabolites reflected endogenous metabolic activity beneficial for productivity, several of these metabolites were tested as medium additives during cell culture. Medium supplementation with citrate improved qP by up to 490% and more than doubled the titer. Together, these studies demonstrate the potential for using metabolomics to discover novel metabolite additives that yield higher volumetric productivity in biologics production processes.

UI MeSH Term Description Entries

Related Publications

Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
January 2005, Cytotechnology,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
April 2010, Current pharmaceutical biotechnology,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
December 2006, Biochimica et biophysica acta,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
May 1980, Cell and tissue kinetics,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
July 1974, The Journal of biological chemistry,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
June 1998, Mutation research,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
January 2013, PloS one,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
September 2006, Cytotechnology,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
August 2008, Bulletin of environmental contamination and toxicology,
Grace Yao, and Kathryn Aron, and Michael Borys, and Zhengjian Li, and Girish Pendse, and Kyongbum Lee
September 2023, Biotechnology and bioengineering,
Copied contents to your clipboard!